Skip to main content

All News

ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.

1 - 5 of 5 Results

mirrorAsymmetry-NPDGamma_ORNL.jpg

A team of scientists has for the first time measured the elusive weak interaction between protons and neutrons in the nucleus of an atom. They had chosen the simplest nucleus consisting of one neutron and one proton for the study.

Leah Broussard leads a study of neutron decay to understand correlations between electrons and antineutrinos as well as subtle distortions in the electron energy spectrum.

Leah Broussard, a physicist at the Department of Energy’s Oak Ridge National Laboratory, has so much fun exploring the neutron that she alternates between calling it her “laboratory” and “playground” for understanding the universe. “The neutron is special,” she said of the sub...

ORNL researchers Gaute Hagen, Masaaki Matsuda, and Parans Paranthaman has been elected fellow of the American Physical Society.

Three researchers from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Physical Society (APS). Fellows of the APS are recognized for their exceptional contributions to the physics enterprise in outstanding resear...

Two neutron diffraction experiments (represented by pink and blue neutron beams) probed a salty solution to reveal its atomic structure. The only difference between the experiments was the identity of the oxygen isotope (O*) that labeled nitrate molecules

Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come

Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.

The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.